Ticker Hub
AVDL
AVDL company profile
Latest price
——
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
3 articles
Price performance
Recent trading
Intraday chart history is not available yet.
Newsroom
Latest AVDL coverage
CompanyDeep DiveNov 21, 2025
Avadel Stock Soars As Lundbeck Outbids Alkermes—Will A Bidding War Break Out?
Lundbeck’s higher $23 bid lifts Avadel’s near-term upside and sparks talk of a bidding war, but its non-binding terms, CVR risks, and the board’s support for Alkermes leave the outcome uncertain.
AVDL
CompanyDeep DiveOct 30, 2025
Avadel’s $2.1 Billion Deal With Alkermes Could Shake Up Sleep Medicine—Here’s How!
Avadel Pharmaceuticals’ $2.1B acquisition by Alkermes underscores Lumryz’s strong growth and profitability, with added upside tied to FDA approval for a new sleep disorder indication.
AVDLALKSJAZZ
BusinessCompanyMar 28, 2025
Avadel Pharma Under Activist Pressure: Can A Potential Buyout Unlock Massive Value For Investors?
Avadel Pharmaceuticals recently surged after ASL Strategic Value Fund publicly called on the company to pursue strategic alternatives—including a potential sale.
AVDL
Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.